First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial

BACKGROUND: Chemotherapy based on platinum is the standard treatment for unresectable malignant pleural mesothelioma (MPM). Liposomal doxorubicin (LD) consists of pegylated phospholipid vesicles that encapsulate doxorubicin-enhancing liposome deposition in the tumour. We evaluated the toxicity profi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arrieta, Ó, Medina, L A, Estrada-Lobato, E, Hernández-Pedro, N, Villanueva-Rodríguez, G, Martínez-Barrera, L, Macedo, E O, López-Rodríguez, V, Motola-Kuba, D, Corona-Cruz, J F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304415/
https://www.ncbi.nlm.nih.gov/pubmed/22353806
http://dx.doi.org/10.1038/bjc.2012.44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304415/
https://www.ncbi.nlm.nih.gov/pubmed/22353806
http://dx.doi.org/10.1038/bjc.2012.44

Ejemplares similares